Subject: IRAQ BW FACILITIES Not Finally Evaluated Intelligence TO FACILITATE ELECTRONIC ACCESS, THIS DOCUMENT HAS BEEN REFORMATTED TO ELIMINATE INFORMATION THAT DOES NOT PERTAIN TO GULF WAR ILLNESS ISSUES OR THAT IS CLASSIFIED. A COPY OF THIS REDACTED DOCUMENT, IN ORIGINAL FORMAT, IS AVAILABLE ON REQUEST. IRAQ CRITICAL NODE BW FACILITIES THERE ARE A NUMBER OF FACILITIES ASSOCIATED WITH THE IRAQI BIOLOGICAL WARFARE (BW) PROGRAM. THESE FACILITIES CAN BE SPLIT INTO TWO BROAD CATEGORIES; PRODUCTION AND STORAGE. BECAUSE THERE ARE A NUMBER OF FACILITIES, NO ONE CAN BE CONSIDERED "THE" CRITICAL NODE. PRODUCTION FACILITIES THE FOLLOWING ARE PRODUCTION LOCATIONS AFFILIATED WITH THE BW PROGRAM. SALMAN PAK ABU GHRAIB VACCINE PLANT TAJI PILOT PLANT SALMAN PAK HAS A HIGH CONTAINMENT BUILDING THAT IS PROBABLY USED FOR RESEARCH, DEVELOPMENT, AND PRODUCTION OF BW AGENTS THE ABU GHRAIB VACCINE PLANT IS THE SITE OF BOTULINUM TOXIN PRODUCTION. TAJI IS THE LOCATION OF A PILOT-SCALE PRODUCTION FACILITY, THIS PLANT IS FOR PRODUCTION OF ANTHRAX. THE PLANT HAS BEEN OPERATIONAL FOR SEVERAL YEARS. A FACILITY THAT MAY BE THIS PILOT PLANT HAS BEEN IDENTIFIED IN THE TAJI AREA. SUSPECT PRODUCTION LOCATIONS THE INFANT FORMULA PLANT AT ABU GHRAIB MAY BE INVOLVED IN THE PRODUCTION OF BW AGENTS. PRODUCING LARGE QUANTITIES OF EITHER ANTHRAX OR BOTULINUM. THE TUWAITHA NUCLEAR RESEARCH CENTER MAY HAVE SOME ROLE IN THE BW PROGRAM. IRAQ'S MAIN PHARMACEUTICAL PLANT, SAMARRA DRUG INDUSTRIES (SDI), PRODUCES-NUMEROUS BIOLOGICAL PRODUCTS AND WAS BUILT IN THE 1970s ALTHOUGH THE PLANT APPEARS TO BE LEGITIMATE AND DOES PRODUCE ANTIBIOTICS, THE EQUIPMENT THERE WOULD ALLOW THE IRAQIS TO PRODUCE A VARIETY OF BW AGENTS. 1.5(c) 74100:74100First Page |Prev Page |Next Page |Src Image
NEWSLETTER
|
Join the GlobalSecurity.org mailing list |
|
|